We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$11.2B
AUM Growth
-$925M
Cap. Flow
-$880M
Cap. Flow %
-7.89%
Top 10 Hldgs %
15.04%
Holding
603
New
165
Increased
118
Reduced
122
Closed
159

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$142M
2
SWKS icon
Skyworks Solutions
SWKS
+$123M
3
EQH icon
Equitable Holdings
EQH
+$118M
4
TGT icon
Target
TGT
+$110M
5
CSCO icon
Cisco
CSCO
+$103M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$155M
2
NXPI icon
NXP Semiconductors
NXPI
+$138M
3
CRM icon
Salesforce
CRM
+$124M
4
AKAM icon
Akamai
AKAM
+$114M
5
PF
Pinnacle Foods, Inc.
PF
+$113M

Sector Composition

Rank Sector Weight
1 Technology 18.82%
2 Industrials 16.36%
3 Energy 11.6%
4 Financials 11.57%
5 Healthcare 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CADE
326
DELISTED
Cadence Bancorporation
CADE
$2.89M 0.03%
+100,000
New +$2.91M
TECX
327
Tectonic Therapeutic
TECX
$606M
$2.86M 0.03%
+8,333
New +$3.01M
IPHI
328
DELISTED
INPHI CORPORATION
IPHI
$2.83M 0.03%
86,739
+70,834
+445% +$2.31M
ALK icon
329
Alaska Air
ALK
$5.58B
$2.82M 0.03%
+46,742
New +$2.89M
AMP icon
330
Ameriprise Financial
AMP
$48.8B
$2.63M 0.02%
18,826
-56,677
-75% -$8.03M
LRMR icon
331
Larimar Therapeutics
LRMR
$432M
$2.56M 0.02%
+20,833
New +$1.77M
METC icon
332
Ramaco Resources Class A
METC
$649M
$2.48M 0.02%
368,022
-246,596
-40% -$1.76M
ASND icon
333
Ascendis Pharma A/S
ASND
$16.8B
$2.47M 0.02%
37,190
+10,490
+39% +$690K
MGY icon
334
Magnolia Oil & Gas
MGY
$5.94B
$2.45M 0.02%
225,000
-1,712,657
-88% -$17.8M
PS
335
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$2.44M 0.02%
+100,000
New +$2.4M
RWGE
336
CALL
DELISTED
Regalwood Global Energy Ltd. Class A Ordinary Shares
RWGE
$2.44M 0.02%
+250,001
New +$2.43M
IMPV
337
DELISTED
Imperva, Inc.
IMPV
$2.42M 0.02%
50,194
-167,612
-77% -$8.02M
AHCO icon
338
CALL
AdaptHealth
AHCO
$759M
$2.4M 0.02%
+250,001
New +$2.43M
SNDX icon
339
Syndax Pharmaceuticals
SNDX
$1.82B
$2.38M 0.02%
338,789
+10,834
+3% +$106K
TTOO
340
DELISTED
T2 Biosystems, Inc
TTOO
$2.37M 0.02%
+61
New +$2.31M
FSTX
341
CALL
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$2.37M 0.02%
50,000
– –
K
342
DELISTED
Kellanova
K
$2.31M 0.02%
+35,146
New +$2.09M
CGBD icon
343
Carlyle Secured Lending
CGBD
$758M
$2.28M 0.02%
133,980
-138,412
-51% -$2.46M
ASUR icon
344
Asure Software
ASUR
$250M
$2.28M 0.02%
+142,869
New +$2.33M
EVER icon
345
EverQuote
EVER
$906M
$2.27M 0.02%
+125,000
New +$2.26M
CSLT
346
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.13M 0.02%
500,000
-133,516
-21% -$502K
GLMD icon
347
Galmed Pharmaceuticals
GLMD
$4.97M
$2.08M 0.02%
+972
New +$1.41M
OBK icon
348
Origin Bancorp
OBK
$1.66B
$2.07M 0.02%
+50,589
New +$1.97M
KALA icon
349
KALA BIO
KALA
$14.5M
$2.06M 0.02%
60
+2
+3% +$76.7K
NITE
350
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$2.05M 0.02%
127,977
+4,093
+3% +$58.4K
12 13
14
15 16

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2018 Portfolio in Review

As of Q2 2018, Alyeska Investment Group held 603 positions worth $11.2B, down 7.7% from $12.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group withdrew a net $880M in Q2 2018, closing 159 positions and reducing 122 holdings. Its most notable exit was IBM, an estimated $155M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Energy.

Against the trend, Alyeska Investment Group opened a new position in Skyworks Solutions worth $122M.

  • Alyeska Investment Group's largest Q2 2018 buy was Skyworks Solutions: 1,261,692 shares worth $122M.
  • Alyeska Investment Group added most to Alphabet (Google) Class A in Q2 2018, an estimated $142M increase.
  • Alyeska Investment Group's biggest Q2 2018 reduction was Salesforce, cutting an estimated $124M.
  • Alyeska Investment Group fully exited IBM in Q2 2018, selling an estimated $155M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $11.2B portfolio in Q2 2018.
  • Alyeska Investment Group opened 165 new positions and closed 159 in Q2 2018.
  • Alyeska Investment Group's portfolio value fell 7.7% quarter-over-quarter to $11.2B.

Based on Alyeska Investment Group's 13F filing for Q2 2018, filed 14 Aug 2018.